ABOUT US

20 years’ experience in pharmaceutical market research makes us experts in: 
- The lifecycle of a study and scope of methodologies 
- Project management 
- A wide range of therapy areas
- Interim strategic reporting 

We have worked with clients on national and international studies, such as Bayer, Merck, Gilead, BI, Novartis, Pfizer and Astra Zeneca together with agencies including Branding Science, Blueprint Partnership, Ripple International, Adelphi Research and Synergy Healthcare Research. We have a rigorous recruitment process and comprehensive training programme for our analysts. 

Our team is made up of bio-science graduates who are methodical, efficient and passionate about detail. We commit to meeting your deadlines and going the extra mile to ensure your data is processed securely, accurately and quickly while focussing on your and your client’s objectives. 

RACHEL PERRETT-YOUSSEF

Director of Replay Research

 

I have 20 years' experience in market research for the pharmaceutical industry. I'm passionate about training my team to my high standards and providing the best quality work and to get your project delivered on time. Please do get in touch if you would like to chat about how we can work together

 

 

As members of the BHBIA, we adhere to the strict guidelines and codes of practice for market research, also in accordance with EPHMRA, ESOMAR and MRS. We comply with all UK laws protecting personal data and are GDPR compliant. All our analysts are fully trained in adverse event reporting.

All audio files are sent using our encrypted FTP site and all analysts sign our terms of service agreement, ensuring client confidentiality at all times.   

We pride ourselves on competitive rates and are happy to discuss budgets and work to your timelines.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.